Biotech, Food & Drug

In today’s hyper-aware environment, concerns about food and drug safety are paramount for both companies and consumers.  The Food and Drug Administration (FDA) and the US Department of Agriculture (USDA) regulates the areas of biotech, food, and drug law. Additionally, laws including the 21st Century Cures Act, and cGMP (Current Good Manufacturing Processes), regulate industry standards/norms in food, cosmetics, and other industry-sectors. Visitors to the National Law Review will find the latest analysis of news, legislation, and upcoming cases/litigation as it relates to this area of law.

With researchers searching for new energy solutions and other developments in biotech, visitors to the NLR will have the opportunity to read content surrounding biosimilars, natural fuel production, medical devices, biotechnology, nanotechnology and materials, and the pharmaceuticals industry. Additionally, content relating to food and drug laws, limits on chemical use in cosmetic products, and other general health/safety topics are covered by the National Law Review and are updated regularly. Additionally, food safety and imports to the United States are also discussed as they become relevant. 

In addition to general health, science, and food/drug, the industry is also closely related to many of the issues related to intellectual property law. New applications for patents, intellectual property, licensing laws, and other areas which are governed by the PTAB court, often crossover into the industry.

New developments in legislation, including the legalization of recreational marijuana has created a new area ripe for legal analysis.  Regulations on how recreational marijuana can be advertised and marketed, distributed and the kind of insurance coverage necessary for dispensaries.  Additionally, employer drug-testing and marijuana statutes have been a hot area of litigation covered by the National Law Review.  

General practices in marketing standards, compliance of federal and state laws/legislation, licensing collaborations, and news related to bringing new products to the market, in the US and abroad, are among the areas visitors to NLR will read about daily. Drug pricing, changes in production standards, regulatory compliance, food safety and handling, drug laws (legalization of marijuana, both recreational and medicinal in the workplace), and labeling and nutritional requirements, are among the many topics covered by the National Law Review daily.

Visitors will always find the latest, up-to-date, most comprehensive coverage on the site. And, news and stories which affect the US, companies which are regulated in the industry, and multinational/international companies, are detailed regularly for NLR readers.

National Law Review Cannabis TwitterFor hourly updates on the latest news about biotech, food & drug, and cannabis laws, regulations, and legislation, be sure to follow our Cannabis X (formerly Twitter) feed, and sign up for complimentary e-news bulletins.

Recent Biotechnology, Food & Drug Administration FDA News

Title
Publication Date Organization
Aug
4
2016
OSHA Blogs on How to Protect Workers from Zika Exposure Holland & Hart LLP
Aug
3
2016
FDA Finalizes Guidance on Low Risk General Wellness Devices McDermott Will & Emery
Aug
3
2016
Italian Medicines Agency Publishes New Concept Paper on Biosimilars Covington & Burling LLP
Aug
2
2016
FDA Publishes Draft Guidance on Codevelopment of Companion Diagnostics Covington & Burling LLP
Aug
2
2016
White Paper Describes Nanotechnology-Inspired Grand Challenge for Future Computing Bergeson & Campbell, P.C.
Aug
2
2016
States’ Efforts for Drug Price Transparency Stymied by the Pharmaceutical Industry Mintz
Aug
2
2016
Mid-Year Medicare 340B Drug Pricing Program Update Foley & Lardner LLP
Aug
2
2016
Truly Whole Foods? FDA Thinks Not ArentFox Schiff LLP
Aug
2
2016
President Signs Bill to Pre-empt Vermont’s GMO Labeling Law Keller and Heckman LLP
Aug
1
2016
FDA Adds Six New Substances to its Inventory of Effective FCS Notifications Keller and Heckman LLP
Aug
1
2016
President Obama Signs S. 764 into Law, Preempting the Vermont GE Labeling Law Keller and Heckman LLP
Aug
1
2016
Governor Kasich Legalizes Marijuana After Boy Band Member Could Not Foley & Lardner LLP
Aug
1
2016
E-Cigarette Makers Contending with New CPSC and FDA Regulations Mintz
Jul
29
2016
Ohio Medical Marijuana Legislation Protects Employers’ Workplace Rights Dinsmore & Shohl LLP
Jul
29
2016
CRISPR Update – July 2016 Foley & Lardner LLP
Jul
28
2016
Advancing New Claims Under the Lanham Act Foley & Lardner LLP
Jul
28
2016
Right to be Smoke-Free Coalition and E-Vapor Industry Trade Associations File Motion for Summary Judgment in Lawsuit Challenging FDA's Deeming Regulation and the Tobacco Control Act Keller and Heckman LLP
Jul
28
2016
Medical Marijuana in Illinois: Billion Dollar Industry in Need of Bank Heyl, Royster, Voelker & Allen, P.C.
Jul
28
2016
FDA Issues Draft Guidance as Part of Precision Medicine Initiative Morgan, Lewis & Bockius LLP
Jul
28
2016
Medical Marijuana in Pennsylvania: Employers Should Prepare for Accelerated MMA Program Implementation Steptoe & Johnson PLLC
Jul
27
2016
FDA Dairy Exports: Milk Matters Keller and Heckman LLP
Jul
26
2016
California Proposes Extending BPA Point-of-Sale Signage and Posting Food-Specific Information on Lead Agency Website Keller and Heckman LLP
Jul
26
2016
FDA Food Safety: Sampling Survey Keller and Heckman LLP
Jul
25
2016
MERCOSUR Revised Resolution on Additives for Plastic Food-Contact Materials Expected Next Year Keller and Heckman LLP
Jul
25
2016
California's Proposition 65: Beep Beep, BPA Labeling Keller and Heckman LLP
Jul
25
2016
EPA Issues Stop-Sale Order to PuriCore, Inc. Bergeson & Campbell, P.C.
Jul
22
2016
Hillary Clinton’s Statements On GMOs Have Varied By Audience MapLight
Jul
22
2016
Slack-fill Litigation on the Rise Armstrong Teasdale
 

NLR Logo

We collaborate with the world's leading lawyers to deliver news tailored for you. Sign Up to receive our free e-Newsbulletins

 

Sign Up for e-NewsBulletins